The present status and future directions of research and development o
n radionuclide generator technology are reported. The recent interest
to develop double-neutron capture reactions for production of in vivo
generators; neutron rich nuclides for radioimmunotherapeutic pharmaceu
ticals; and advances with ultrashort lived generators is highlighted.
Emphasis is focused on: production of the parent radionuclide; the sel
ection and the evaluation of support materials and eluents with respec
t to the resultant radiochemical yield of the daughter, and the breakt
hrough of the radionuclide parent; and, the uses of radionuclide gener
ators in radiopharmaceutical chemistry, biomedical and industrial appl
ications. The Zn-62 --> Cu-62, Ni-66 --> Cu-66, Rh-103m --> Rh-103, W-
188 --> Re-188 and the Ac-225 --> Fr-221 --> Bi-213 generators are pre
dicted to be emphasized for future development. Coverage of the Mo-99
--> Tc-99m generator was excluded, as it the subject of another review
. The literature search ended June, 1996.